The efficacy of Lactobacillus reuteri DSM 17938 in infants and children: a review of the current evidence

European Journal of Pediatrics

Volumn 173, Issue 10, 2014, Pages 1327-1337

  Urbańska, Magdalena ^a   Szajewska, Hania ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Probiotics; Randomized controlled trial; Systematic review

Indexed keywords

PROBIOTIC AGENT;

ABDOMINAL PAIN; ACUTE GASTROENTERITIS; ARTICLE; ARTIFICIAL MILK; BREAST MILK; CHILD; COLIC; CONSTIPATION; COST EFFECTIVENESS ANALYSIS; CRYING; DAY CARE; DIARRHEA; GASTROESOPHAGEAL REFLUX; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INFANT; LACTOBACILLUS REUTERI; LENGTH OF STAY; NECROTIZING ENTEROCOLITIS; PREMATURITY; REHYDRATION; SEPSIS; STOMACH EMPTYING; STOMACH MOTILITY; ACUTE DISEASE; CROSS INFECTION; GASTROENTERITIS; GASTROINTESTINAL DISEASES; SAFETY;

ABDOMINAL PAIN; ACUTE DISEASE; CHILD; COLIC; CROSS INFECTION; DIARRHEA; GASTROENTERITIS; GASTROINTESTINAL DISEASES; HUMANS; INFANT; LACTOBACILLUS REUTERI; PROBIOTICS; SAFETY;

EID: 84918784101     PISSN: 03406199     EISSN: 14321076     Source Type: Journal    
DOI: 10.1007/s00431-014-2328-0     Document Type: Article

References (31)

1. Agustina R, Bovee-Oudenhoven IM, Lukito W, Fahmida U, van de Rest O, Zimmermann MB, Firmansyah A, Wulanti R, Albers R, van den Heuvel EG, Kok FJ (2013) Probiotics Lactobacillus reuteri DSM 17938 and Lactobacillus casei CRL 431 modestly increase growth, but not iron and zinc status, among Indonesian children aged 1–6 years. J Nutr 143(7):1184–1193
2. Axelson LT, Chung TC, Dobrogosz WJ, Lindgren SE (1989) Production of a broad spectrum antimicrobial substance by Lactobacillus reuteri. Microb Ecol Health Dis 2:131–136
3. Chung TC, Axelsson L, Lindgren SE, Dobrogosz WJ (1989) In vitro studies on reuterin synthesis by Lactobacillus reuteri. Microb Ecol Health Dis 2:137–144
4. Coccorullo P, Strisciuglio C, Martinelli M, Miele E, Greco L, Staiano A (2010) Lactobacillus reuteri (DSM 17938) in infants with functional chronic constipation: a double-blind, randomized, placebo- controlled study. J Pediatr 157(4):598–602
5. Dinleyici EC, PROBAGE Study Group, Vandenplas Y (2014) Lactobacillus reuteri DSM 17938 effectively reduces the duration of acute diarrhoea in hospitalised children. Acta Paediatr. doi:10.1111/apa.12617
6. Egervärn M, Lindmark H, Olsson J, Roos S (2010) Transferability of a tetracycline resistance gene from probiotic Lactobacillus reuteri to bacteria in the gastrointestinal tract of humans. Antonie Van Leeuwenhoek 97(2):189–200
7. FDA (2012) Available via DIALOG: http://www.fda.gov/Food/IngredientsPackagingLabeling/GRAS/NoticeInventory/ucm300525.htm. Accessed 2 Mar 2014
8. Food and Agriculture Organization of the United Nations (FAO) (2001) Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. Available via DIALOG: http://www.who.int/foodsafety/publications/fs_management/en/probiotics.pdf. Accessed 25 Feb 2014
9. Francavilla R, Lionetti E, Castellaneta S, Ciruzzi F, Indrio F, Masciale A, Fontana C, La Rosa MM, Cavallo L, Francavilla A (2012) Randomised clinical trial: Lactobacillus reuteri DSM 17938 vs. placebo in children with acute diarrhoea–a double-blind study. Aliment Pharmacol Ther 36(4):363–369
10. Garofoli F, Civardi E, Indrio F, Mazzucchelli I, Angelini M, Tinelli C, Stronati M (2014) The early administration of Lactobacillus reuteri DSM 17938 controls regurgitation episodes in full-term breastfed infants. Int J Food Sci Nutr. doi:10.3109/09637486.2014.898251
11. Grześkowiak Ł, Isolauri E, Salminen S, Gueimonde M (2011) Manufacturing process influences properties of probiotic bacteria. Br J Nutr 105(6):887–894
12. Gutierrez- Castrellon P, Lopez- Velazquez G, Diaz- Garcia L, Jimenez- Gutierrez C, Mancilla- Ramirez J, Estevez- Jimenez J, Parra M (2014) Diarrhea in preschool children and Lactobacillus reuteri: a randomized controlled trial. Pediatrics 133:e904
13. Indrio F, Di Mauro A, Riezzo G, Civardi E, Intini C, Corvaglia L, Ballardini E, Bisceglia M, Cinquetti M, Brazzoduro E, Del Vecchio A, Tafuri S, Francavilla R (2013) Prophylactic use of a probiotic in the prevention of colic, regurgitation, and functional constipation: a randomized clinical trial. JAMA Pediatr 168(3):228–233
14. Indrio F, Riezzo G, Raimondi F, Bisceglia M, Filannino A, Cavallo L, Francavilla R (2011) Lactobacillus reuteri accelerates gastric emptying and improves regurgitation in infants. Eur J Clin Investig 41(4):417–422
15. Jones SE, Versalovic J (2009) Probiotic Lactobacillus reuteri biofilms produce antimicrobial and anti-inflammatory factors. BMC Microbiol 11(9):35
16. Lin YP, Thibodeaux CH, Peña JA, Ferry GD, Versalovic J (2008) Probiotic Lactobacillus reuteri suppress proinflammatory cytokines via c-Jun. Inflamm Bowel Dis 14(8):1068–1083
17. Liu Y, Fatheree NY, Mangalat N, Rhoads JM (2010) Human-derived probiotic Lactobacillus reuteri strains differentially reduce intestinal inflammation. Am J Physiol Gastrointest Liver Physiol 299(5):G1087–G1096
18. Liu Y, Fatheree NY, Mangalat N, Rhoads JM (2012) Lactobacillus reuteri strains reduce incidence and severity of experimental necrotizing enterocolitis via modulation of TLR4 and NF-κB signaling in the intestine. Am J Physiol Gastrointest Liver Physiol 302(6):G608–G617
19. Oncel MY, Sari FN, Arayici S, Guzoglu N, Erdeve O, Uras N, Oguz SS, Dilmen U (2014) Lactobacillus reuteri for the prevention of necrotising enterocolitis in very low birthweight infants: a randomised controlled trial. Arch Dis Child Fetal Neonatal Ed 99(2):F110–F115
20. Reuter G (2001) The Lactobacillus and Bifidobacterium microflora of the human intestine: composition and succession. Curr Issues Intest Microbiol 2:43–53
21. Rojas MA, Lozano JM, Rojas MX, Rodriguez VA, Rondon MA, Bastidas JA, Perez LA, Rojas C, Ovalle O, Garcia-Harker JE, Tamayo ME, Ruiz GC, Ballesteros A, Archila MM, Arevalo M (2012) Prophylactic probiotics to prevent death and nosocomial infection in preterm infants. Pediatrics 130(5):e1113–e1120
22. Romano C, Ferrau V, Cavataio F, Iacono G, Spina M, Lionetti E, Comisi F, Famiani A, Comito D (2010) Lactobacillus reuteri in children with functional abdominal pain (FAP). J Paediatr Child Health 824
23. Rosander A, Connolly E, Roos S (2008) Removal of antibiotic resistance gene-carrying plasmids from Lactobacillus reuteri ATCC 55730 and characterization of the resulting daughter strain, L. reuteri DSM 17938. Appl Environ Microbiol 74(19):6032–6040
24. Savino F, Cordisco L, Tarasco V, Palumeri E, Calabrese R, Oggero R, Roos S, Matteuzzi D (2010) Lactobacillus reuteri DSM 17938 in infantile colic: a randomized, double-blind, placebo-controlled trial. Pediatrics 126(3):e526–e533
25. Sung V, Hiscock H, Tang ML, Mensah FK, Nation ML, Satzke C, Heine RG, Stock A, Barr RG, Wake M (2014) Treating infant colic with the probiotic Lactobacillus reuteri: double blind, placebo controlled randomised trial. BMJ 1(348):g2107
26. Szajewska H, Gyrczuk E, Horvath A (2013) Lactobacillus reuteri DSM 17938 for the management of infantile colic in breastfed infants: a randomized, double-blind, placebo-controlled trial. J Pediatr 162:257–262
27. Szajewska H, Guarino A, Hojsak I, Indrio F, Kolacek S, Shamir R, Vandenplas Y, Weizman Z (2014) Use of Probiotics for Management of Acute Gastroenteritis: A Position Paper by the ESPGHAN Working Group for Probiotics and Prebiotics. J Pediatr Gastroenterol Nutr 58(4):531–539
28. Szajewska H, Urbańska M, Chmielewska A, Weizman Z, Shamir R (2014) Meta-analysis: Lactobacillus reuteri strain DSM 17938 (and the original strain ATCC 55730) for treating acute gastroenteritis in children. Benefic Microbes 24:1–9
29. Talarico TL, Casas IA, Chung TC, Dobrogosz WJ (1988) Production and isolation of reuterin, a growth inhibitor produced by Lactobacillus reuteri. Antimicrob Agents Chemother 32(12):1854–1858
30. Valeur N, Engel P, Carbajal N, Connolly E, Ladefoged K (2004) Colonization and immunomodulation by Lactobacillus reuteri ATCC 55730 in the human gastrointestinal tract. Appl Environ Microbiol 70(2):1176–1181
31. Wanke M, Szajewska H (2012) Lack of an effect of Lactobacillus reuteri DSM 17938 in preventing nosocomial diarrhea in children: a randomized, double-blind, placebo-controlled trial. J Pediatr 161(1):40–43.e1